Study Reveals Mechanism Behind Sex Differences in Severe COVID-19 Outcomes
A study published in Frontiers in Cellular and Infection Microbiology by Sandra Bižić-Radulović and colleagues at the University Clinical Center of Serbia provides insights into the mechanisms by which sex steroids modulate inflammatory pathways in response to SARS-CoV-2. This molecular interplay may underlie the higher rates of respiratory failure and mortality observed in male patients.
Cell-Specific Effects of Sex Steroids on Inflammation
Experiments on human lung microvascular endothelial cells (HULEC-5a), THP-1 monocytic cells, and primary immune cells from COVID-19 patients revealed distinct roles for sex steroids. SARS-CoV-2 reduced estrogen receptor (ESR1) expression in endothelial cells. In contrast, the virus activated inflammatory pathways like NFκB and STAT3 in monocytic cells, with DHT enhancing these responses. In neutrophils, β-estradiol inhibited NFκB signaling, while DHT stimulated it. Monocyte migration across endothelial barriers—linked to vascular inflammation and thrombosis—was significantly increased by DHT. These findings highlight the complex, cell-type-specific effects of sex hormones on viral immunity.
Implications for Therapeutic Strategies
The study suggests that targeting androgen-responsive pathways could mitigate severe inflammation in COVID-19. However, the non-monotonic dose responses observed—where low-dose DHT amplified signaling while higher flutamide concentrations did not—emphasize the need for careful pharmacological characterization.
Researchers caution that androgen receptor antagonists may not uniformly suppress inflammation across all cell types, highlighting the importance of personalized approaches. The work also prompts questions about how these mechanisms apply to newer SARS-CoV-2 variants, which may alter cytokine profiles and viral replication dynamics.
Limitations and Future Directions
The study’s authors note limitations, including the use of cells from a single male donor and the focus on the Wuhan-1 variant. The findings contribute to a growing body of evidence linking sex hormones to immune regulation, with potential applications beyond COVID-19. By elucidating the molecular basis of sex differences in disease severity, the study offers a framework for developing targeted therapies.
What Remains Unclear?
While the study identifies key signaling pathways, it does not resolve whether estrogen’s protective effects are sufficient to counteract androgen-driven inflammation in vivo. Researchers plan to extend this work to vaccinated individuals and variants with distinct inflammatory profiles.
Androgen Signaling Amplifies Inflammatory Responses in Men's COVID-19
Androgen signaling amplifies inflammatory responses in immune cells, potentially worsening COVID-19 severity in men.
Related reading